| Structure |
Chemical Name |
CAS |
MF |
 |
N-desethyl Etonitazene |
2732926-26-8 |
C20H24N4O3 |
 |
Piperazine, 1-(cyclobutylmethyl)- (9CI) |
82534-54-1 |
C9H18N2 |
![2-(5-Chloro-[1,1'-biphenyl]-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane](/CAS/20211123/GIF/2750016-14-7.gif) |
2-(5-Chloro-[1,1'-biphenyl]-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
2750016-14-7 |
C18H20BClO2 |
 |
1,4-Diazepan-5-one hydrochloride |
208245-76-5 |
C5H11ClN2O |
 |
1,5-Pentanediaminium, N1,N1,N1,N5,N5,N5-hexaethyl-, hydroxide (1:2) |
109591-12-0 |
C17H41N2O+ |
 |
11-Prostaglandin F2a |
|
|
 |
2,4-DICHLORO-5-METHYL-PHENYLAMINE |
17601-75-1 |
C7H7Cl2N |
![2-Oxa-4,9-diazaspiro[5.5]undecan-3-one](/CAS/20210305/GIF/561314-58-7.gif) |
2-Oxa-4,9-diazaspiro[5.5]undecan-3-one |
561314-58-7 |
C8H14N2O2 |
 |
Ceftazidime Mother Nucleus Double-Bond Shift |
|
|
 |
4-Pyrimidinecarboxylic acid |
31462-59-6 |
C5H4N2O2 |
 |
(3R,4R,5R)-Oseltamivir |
|
|
 |
DIMETHYL PYRAZINE-2,5-DICARBOXYLATE |
13051-89-3 |
C8H8N2O4 |
![Pyrazolo[1,5-a]pyridine](/CAS/GIF/274-56-6.gif) |
Pyrazolo[1,5-a]pyridine |
274-56-6 |
C7H6N2 |
 |
8-BROMOQUINOLIN-2(1H)-ONE |
67805-67-8 |
C9H6BrNO |
 |
Pyrimidine, 2-chloro-4-(4-chlorophenoxy)-5-fluoro- |
1503263-51-1 |
C10H5Cl2FN2O |
![(1R)-7-Chloro-6-fluoro-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione](/CAS/20211123/GIF/2300966-23-6.gif) |
(1R)-7-Chloro-6-fluoro-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione |
2300966-23-6 |
C16H14ClFN4O2 |
 |
(9H-fluoren-9-yl)methyl (R)-(3-(2-bromophenyl)-1-(methylamino)-1-oxopropan-2-yl)carbamate |
|
|
 |
5-BROMO-3-CHLORO-2-METHYLPYRIDINE |
914358-72-8 |
C6H5BrClN |
 |
7-Hydroxyquinolinone |
70500-72-0 |
C9H7NO2 |
 |
5-GERANOXY-7-METHOXYCOUMARIN |
7380-39-4 |
C20H24O4 |
 |
6-BROMO-1H-INDAZOLE-3-CARBALDEHYDE |
885271-72-7 |
C8H5BrN2O |
 |
4,6-dichloro-2-cyclobutylpyrimidine |
1353856-95-7 |
C8H8Cl2N2 |
 |
Azacitidine Isomer |
|
|
 |
6-FLUORO-4-HYDROXYCOUMARIN |
1994-13-4 |
C9H5FO3 |
 |
Cefazolin Related Compound D |
|
|
 |
Sugammadex sodium hexabromide intermediate |
|
|
 |
(3S,5R,2R,3S)-posaconazole |
|
|
![7-oxaspiro[3.5]nonan-2-amine](/CAS/20200331/GIF/1374658-89-5.gif) |
7-oxaspiro[3.5]nonan-2-amine |
1374658-89-5 |
C8H15NO |
 |
2',3',5'-TRI-O-BENZOYLINOSINE |
6741-88-4 |
C31H24N4O8 |
 |
2 6-BIS[(4S 5S)-4-METHYL-5-PHENYL-2-OXA& |
185346-20-7 |
C25H23N3O2 |
 |
5-AMINO-2'-DEOXYURIDINE FREE BASE |
5536-30-1 |
C9H13N3O5 |
 |
2,2-dimethoxycyclohexanol |
63703-34-4 |
C8H16O3 |
![(1R-cis)-3-(phenylmethyl)-4-Thia-2,6-diazabicyclo[3.2.0]hept-2-en-7-one](/CAS/20200401/GIF/34103-69-0.gif) |
(1R-cis)-3-(phenylmethyl)-4-Thia-2,6-diazabicyclo[3.2.0]hept-2-en-7-one |
34103-69-0 |
C11H10N2OS |
![9H-Carbazole-3-carbonitrile, 9-[3-(9H-carbazol-9-yl)phenyl]-](/CAS/20200401/GIF/1392506-99-8.gif) |
9H-Carbazole-3-carbonitrile, 9-[3-(9H-carbazol-9-yl)phenyl]- |
1392506-99-8 |
C31H19N3 |
 |
(9H-fluoren-9-yl)methyl N-(carbamoylmethyl)carbamate |
115057-37-9 |
C17H16N2O3 |
 |
Roxadustat Impurity |
1959587-35-9 |
C20H17NO6 |
 |
Benzonitrile, 3-(2-amino-6-chloro-4-pyrimidinyl)-2-methyl- |
2239278-05-6 |
C12H9ClN4 |
 |
Inosine API manufacturers |
|
|
 |
3’-deoxyinosine |
|
|
 |
(S)-2-(2,2,2-trifluoroethyl)piperazine dihydrochloride |
|
|
 |
Activated DPG Subunit |
1155309-89-9 |
C51H53ClN7O7P |
 |
Acetoxy Ceftazidime Intermediate |
|
|
 |
Flomoxef Intermediate FXMT |
|
|
 |
2-Morpholino-6-oxo-1,6-dihydropyrimidine-4-carboxylic acid |
933686-76-1 |
C9H11N3O4 |
 |
4-METHYL 6-HYDROXY 7-ACETOXY COUMARIN |
46895-13-0 |
C12H10O6 |
![1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXYLIC ACID METHYL ESTER](/CAS/GIF/849067-96-5.gif) |
1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXYLIC ACID METHYL ESTER |
849067-96-5 |
C9H8N2O2 |
 |
Pyrazole |
288-13-1 |
C3H4N2 |
 |
9-OXO-11ALPHA,15S-DIHYDROXY-PROST-13E-EN-1-OIC-3,3,4,4-D4 ACID |
211105-33-8 |
C20H30D4O5 |
 |
7,10-Dioxa-2,5-diazaundecanoic acid, 4,9-dioxo-11-phenyl-, 9H-fluoren-9-ylmethyl ester |
1599440-07-9 |
C27H26N2O6 |
![2,3,5,6-1H,4H-TETRAHYDROQUINOLIZINO[9,9A,1-GH]COUMARIN](/CAS/GIF/58336-35-9.gif) |
2,3,5,6-1H,4H-TETRAHYDROQUINOLIZINO[9,9A,1-GH]COUMARIN |
58336-35-9 |
C15H15NO2 |
 |
3-Fluorobenzylamine |
100-82-3 |
C7H8FN |
 |
1,3,5-Triazine, 2-(8-chloro-3-dibenzofuranyl)-4,6-diphenyl- |
2361279-84-5 |
C27H16ClN3O |
 |
4-Piperidinecarboxylic acid, 3-methyl-4-phenyl-, phenylmethyl ester, (3S,4R)- |
2357209-42-6 |
C20H23NO2 |
 |
4-(3-Chlorophenyl)-2-(4-nitrophenoxy)-1,3,2-dioxaphosphinane 2-oxide |
883989-27-3 |
C15H13ClNO6P |
 |
2-(DiMethylaMino)acetaldehyde sulfite |
1413945-87-5 |
C4H11NO4S |
 |
sacubitril |
1038924-61-6 |
C17H17NO |
![tert-butyl 9-oxo-3-azabicyclo[3.3.1]nonane-3-carboxylate](/CAS/20150408/GIF/512822-34-3.gif) |
tert-butyl 9-oxo-3-azabicyclo[3.3.1]nonane-3-carboxylate |
512822-34-3 |
C13H21NO3 |
 |
Formamidinium Lead Iodide |
1451592-07-6 |
CH8I3N2Pb |
 |
Velpatasvir intermediate |
1378391-45-7 |
C44H53N7O7 |
 |
Octenyl succinic anhydride |
26680-54-6 |
C12H18O3 |
 |
1-CHLORO-3,3,3-TRIFLUOROACETONE |
431-37-8 |
C3H2ClF3O |
 |
(R)-1-benzyl-5-methyl-1,4-diazepane |
1620097-06-4 |
C13H20N2 |
![ETHYL 2-[3-FLUORO-(TRIFLUOROMETHYL)PHENYL]-4-METHYL-THIAZOLE-5-CARBOXYLATE](/StructureFile/ChemBookStructure8/GIF/CB6308434.gif) |
ETHYL 2-[3-FLUORO-(TRIFLUOROMETHYL)PHENYL]-4-METHYL-THIAZOLE-5-CARBOXYLATE |
317319-21-4 |
C14H11F4NO2S |
 |
4,6-Dichloro-2-isobutylpyrimidine |
1164116-18-0 |
C8H10Cl2N2 |
 |
Br-PEG1-NHBoc |
164332-88-1 |
C9H18BrNO3 |
![3-Bromo-pyrrolo[1,2-a]pyrimidine-6-carboxylic acid](/CAS/20180703/GIF/1823918-84-8.gif) |
3-Bromo-pyrrolo[1,2-a]pyrimidine-6-carboxylic acid |
1823918-84-8 |
C8H5BrN2O2 |
![(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride](/CAS/20180703/GIF/1701403-10-2.gif) |
(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride |
1701403-10-2 |
C22H23ClN6O |
 |
Methyl 2-(hydroxymethyl)nicotinate |
1697289-97-6 |
C8H9NO3 |
 |
Benzenemethanol, 4-cyclohexyl-3-(trifluoromethyl)- |
957205-23-1 |
C14H17F3O |
![(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid](/CAS/20180703/GIF/1616342-45-0.gif) |
(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid |
1616342-45-0 |
C15H16N2O6 |
 |
5-FLUORO-1H-INDAZOLE-3-CARBALDEHYDE |
485841-48-3 |
C8H5FN2O |
 |
4-Fluoro-5-isoquinolinesulfonyl chloride hydrochloride (1:1) |
906820-08-4 |
C9H5ClFNO2S.ClH |
 |
Azithromycin F |
612069-26-8 |
C38H72N2O13 |
 |
Coumarin 102 |
41267-76-9 |
C16H17NO2 |
![(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-METHANOL](/CAS/GIF/849067-97-6.gif) |
(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-METHANOL |
849067-97-6 |
C8H8N2O |
![(1H-BENZO[D]IMIDAZOL-2-YL)METHANAMINE](/CAS/GIF/5805-57-2.gif) |
(1H-BENZO[D]IMIDAZOL-2-YL)METHANAMINE |
5805-57-2 |
C8H9N3 |
 |
Sodium 1-(2-hydroxyethyl)-1H-tetrazol-5-ylthiolate |
400827-72-7 |
C3H5N4NaOS |
 |
DMAC-BP |
1685287-55-1 |
C43H36N2O |
![tert-butyl endo-3-hydroxy-9-azabicyclo[3.3.1]nonane-9-carboxylate](/CAS/20180601/GIF/934180-37-7.gif) |
tert-butyl endo-3-hydroxy-9-azabicyclo[3.3.1]nonane-9-carboxylate |
934180-37-7 |
C13H23NO3 |
![(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate](/CAS/20200331/GIF/1187595-90-9.gif) |
(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate |
1187595-90-9 |
C22H27N7O4S |
 |
(6R,7S)-Cefuroxime |
|
C16H16N4O8S |
 |
Cefdinir Impurity E (CP) |
|
|
![Methyl 8-hydroxy-3-(2-methoxy-2-oxoethyl)-6-methyl-9-oxo-9H-furo[3,4-b]chromene-1-carboxylate](/CAS/20180601/GIF/96287-41-1.gif) |
Methyl 8-hydroxy-3-(2-methoxy-2-oxoethyl)-6-methyl-9-oxo-9H-furo[3,4-b]chromene-1-carboxylate |
96287-41-1 |
C17H14O8 |
![(6-methyl-2-p-tolyl-2,3-dihydro-imidazo[1,2-a]pyridin-3-yl)-oxoacetic acid](/CAS/20200401/GIF/927820-48-2.gif) |
(6-methyl-2-p-tolyl-2,3-dihydro-imidazo[1,2-a]pyridin-3-yl)-oxoacetic acid |
927820-48-2 |
C17H14N2O3 |
![7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione](/CAS/20200611/GIF/1370250-39-7.gif) |
7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione |
1370250-39-7 |
C17H17N3O4 |
 |
(S)-4-((9H-fluoren-9-yl)methyl) 3-methyl 2H-1,4-oxazine-3,4(3H)-dicarboxylate |
942152-97-8 |
C21H19NO5 |
 |
Isopropyl 5-(Diphenylphosphoryl)pentanoate |
2088449-88-9 |
C20H25O3P |
 |
3-Cyano-1,2,4-triazole |
3641-10-9 |
C3H2N4 |
 |
1-Hydroxyethylethoxypiperazine |
13349-82-1 |
C8H18N2O2 |
 |
1-BENZYLOXYCARBONYLPIPERIDINE-3-CARBONYL CHLORIDE |
216502-94-2 |
C14H16ClNO3 |
 |
5-BROMO-2-METHYLBENZOTHIAZOLE |
63837-11-6 |
C8H6BrNS |
 |
Triphenylsulfonium chloride |
4270-70-6 |
C18H15ClS |
 |
4-Bromomethypiperidine-1-carboxylic acid tert-butyl ester |
158407-04-6 |
C11H20BrNO2 |
 |
ACETIC ACID 2-PHENOXYETHYL ESTER |
6192-44-5 |
C10H12O3 |
![4-Chloro-1-(2-methylpropyl)-1H-imidazo[4,5-c]quinoline](/CAS/20180906/GIF/99010-64-7.gif) |
4-Chloro-1-(2-methylpropyl)-1H-imidazo[4,5-c]quinoline |
99010-64-7 |
C14H14ClN3 |
 |
ETHYL 1-HYDROXYCYCLOPENTANE-CARBOXYLATE |
41248-23-1 |
C8H14O3 |
 |
Danshen injection intermediate |
|
|
![ethyl 4'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3,4,5-tetrahydro-[1,1'-biphenyl]-4-carboxylate](/CAS/20200401/GIF/1418754-60-5.gif) |
ethyl 4'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3,4,5-tetrahydro-[1,1'-biphenyl]-4-carboxylate |
1418754-60-5 |
C21H29BO4 |
 |
BMK Glycidic Acid (sodium salt) |
5449-12-7 |
C10H11NaO3 |
 |
Dibenzofuran, 3-bromo-6-phenyl- |
2181786-99-0 |
C18H11BrO |